Atlas Trials

Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.

Clinical trial NCT07051928 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07051928
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Non Small Cell Lung Cancer
Start date
2025-07-01
Primary completion
2027-07-01
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.